Controlled drug release from lung-targeted nanocarriers via chemically mediated shell permeabilisation

International Journal of Pharmaceutics

Volumn 511, Issue 2, 2016, Pages 1033-1041

  Chen, Hanpeng ^a   Woods, Arcadia ^a   Forbes, Ben ^a   Jones, Stuart ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Controlled drug release; Dissolution; Inhaled drug delivery; Lipid nanoparticles; Poly(vinyl alcohol); Polymer nanoparticles; Rifampicin

Indexed keywords

LIPIDIC SHELLED NANOCARRIER; NANOCARRIER; POLOXAMER; POLYMER; RIFAMPICIN; SHELLED NANOCARRIER; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; DRUG CARRIER; NANOPARTICLE;

AIRWAY; ARTICLE; CELL PH; CHEMICAL ANALYSIS; CLINICAL EVALUATION; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG HYDROLYSIS; ELECTROPORATION; ENDOSOME; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; ADMINISTRATION AND DOSAGE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; DRUG RELEASE; LUNG; METABOLISM; PERMEABILITY; PROCEDURES;

DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; LUNG; NANOPARTICLES; PERMEABILITY; RIFAMPIN;

EID: 84982097953     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2016.08.012     Document Type: Article

References (40)

1. Abdel-Mottaleb, M.M., Neumann, D., Lamprecht, A., In vitro drug release mechanism from lipid nanocapsules (LNC). Int. J. Pharm. 390 (2010), 208–213.
2. Bhise, S.B., More, A.B., Malayandi, R., Formulation and in vitro evaluation of rifampicin loaded porous microspheres. Sci. Pharm., 78, 2010, 291.
3. Chana, J., Forbes, B., Jones, S.A., The synthesis of high molecular weight partially hydrolysed poly (vinyl alcohol) grades suitable for nanoparticle fabrication. J. Nanosci. Nanotechnol. 8 (2008), 5739–5747.
4. Chana, J., Forbes, B., Jones, S.A., Triggered-release nanocapsules for drug delivery to the lungs. Nanomed. Nanotechnol. Biol. Med. 11 (2015), 89–97.
5. Clayden, J., Greeves, N., Warren, S., Organic Chemistry. 2nd ed., 2012, Oxford University Press, UK.
6. Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand-Brynaert, J., Feron, O., Préat, V., Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J. Controlled Release 133 (2009), 11–17.
7. DeMerlis, C., Schoneker, D., Review of the oral toxicity of polyvinyl alcohol (PVA). Food Chem. Toxicol. 41 (2003), 319–326.
8. Firestone, M.A., Wolf, A.C., Seifert, S., Small-angle X-ray scattering study of the interaction of poly (ethylene oxide)-b-poly (propylene oxide)-b-poly (ethylene oxide) triblock copolymers with lipid bilayers. Biomacromolecules 4 (2003), 1539–1549.
9. Ganta, S., Devalapally, H., Shahiwala, A., Amiji, M., A review of stimuli-responsive nanocarriers for drug and gene delivery. J. Controlled Release 126 (2008), 187–204.
10. Heurtault, B., Saulnier, P., Pech, B., Proust, J.-E., Benoit, J.-P., A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 19 (2002), 875–880.
11. Holmkvist, A.D., Friberg, A., Nilsson, U.J., Schouenborg, J., Hydrophobic ion pairing of a minocycline/Ca 2+/AOT complex for preparation of drug-loaded PLGA nanoparticles with improved sustained release. Int. J. Pharm. 499 (2016), 351–357.
12. Janes, K.A., Fresneau, M.P., Marazuela, A., Fabra, A., Alonso, M.a.J., Chitosan nanoparticles as delivery systems for doxorubicin. J. Controlled Release 73 (2001), 255–267.
13. Jones, M.-C., Jones, S.A., Riffo-Vasquez, Y., Spina, D., Hoffman, E., Morgan, A., Patel, A., Page, C., Forbes, B., Dailey, L.A., Quantitative assessment of nanoparticle surface hydrophobicity and its influence on pulmonary biocompatibility. J. Controlled Release 183 (2014), 94–104.
14. Kean, T., Thanou, M., Biodegradation, biodistribution and toxicity of chitosan. Adv. Drug Deliv. Rev. 62 (2010), 3–11.
15. Lahnstein, K., Schmehl, T., Rüsch, U., Rieger, M., Seeger, W., Gessler, T., Pulmonary absorption of aerosolized fluorescent markers in the isolated rabbit lung. Int. J. Pharm. 351 (2008), 158–164.
16. Madlova, M., Jones, S., Zwerschke, I., Ma, Y., Hider, R., Forbes, B., Poly (vinyl alcohol) nanoparticle stability in biological media and uptake in respiratory epithelial cell layers in vitro. Eur. J. Pharm. Biopharm. 72 (2009), 438–443.
17. Mao, G., Sukumaran, S., Beaucage, G., Saboungi, M.-L., Thiyagarajan, P., PEO-PPO-PEO block copolymer micelles in aqueous electrolyte solutions: effect of carbonate anions and temperature on the micellar structure and interaction. Macromolecules 34 (2001), 552–558.
18. Mindell, J.A., Lysosomal acidification mechanisms. Annu. Rev. Physiol. 74 (2012), 69–86.
19. Mukherjee, B., Santra, K., Pattnaik, G., Ghosh, S., Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers. Int. J. Nanomed., 3, 2008, 487.
20. Mura, S., Nicolas, J., Couvreur, P., Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12 (2013), 991–1003.
21. Natarajan, J.V., Nugraha, C., Ng, X.W., Venkatraman, S., Sustained-release from nanocarriers: a review. J. Controlled Release 193 (2014), 122–138.
22. Nayak, A.P., Tiyaboonchai, W., Patankar, S., Madhusudhan, B., Souto, E.B., Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids Surf. B Biointerfaces 81 (2010), 263–273.
23. Ohashi, K., Kabasawa, T., Ozeki, T., Okada, H., One-step preparation of rifampicin/poly (lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. J. Controlled Release 135 (2009), 19–24.
24. Pandey, R., Khuller, G., Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis 85 (2005), 227–234.
25. Pandey, R., Sharma, A., Zahoor, A., Sharma, S., Khuller, G., Prasad, B., Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J. Antimicrob. Chemother. 52 (2003), 981–986.
26. Parveen, S., Misra, R., Sahoo, S.K., Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed. Nanotechnol. Biol. Med. 8 (2012), 147–166.
27. Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R., Langer, R., Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2 (2007), 751–760.
28. Pinkerton, N.M., Grandeury, A., Fisch, A., Brozio, B.U., Riebesehl, J.R., Prud'homme, R.K., Formation of stable nanocarriers by in situ ion pairing during block-copolymer-directed rapid precipitation. Mol. Pharm. 10 (2012), 319–328.
29. Sabzevari, A., Adibkia, K., Hashemi, H., Hedayatfar, A., Mohsenzadeh, N., Atyabi, F., Ghahremani, M.H., Dinarvand, R., Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies. Eur. J. Pharm. Biopharm. 84 (2013), 63–71.
30. Singh, S., Mariappan, T., Sharda, N., Singh, B., Degradation of rifampicin, isoniazid and pyrazinamide from prepared mixtures and marketed single and combination products under acid conditions. Pharm. Pharmacol. Commun. 6 (2000), 491–494.
31. Singh, H., Bhandari, R., Kaur, I.P., Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH. Int. J. Pharm. 446 (2013), 106–111.
32. Song, Y.H., Shin, E., Wang, H., Nolan, J., Low, S., Parsons, D., Zale, S., Ashton, S., Ashford, M., Ali, M., A novel in situ hydrophobic ion paring (HIP) formulation strategy for clinical product selection of a nanoparticle drug delivery system. J. Controlled Release 229 (2016), 106–119.
33. Soppimath, K.S., Aminabhavi, T.M., Kulkarni, A.R., Rudzinski, W.E., Biodegradable polymeric nanoparticles as drug delivery devices. J. Controlled Release 70 (2001), 1–20.
34. Sosnik, A., Carcaboso, Á.M., Glisoni, R.J., Moretton, M.A., Chiappetta, D.A., New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery. Adv. Drug Deliv. Rev. 62 (2010), 547–559.
35. Wang, Y., Kho, K., Cheow, W.S., Hadinoto, K., A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid–polymer hybrid nanoparticles. Int. J. Pharm. 424 (2012), 98–106.
36. Xu, Y., Du, Y., Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm. 250 (2003), 215–226.
37. Yang, B., Guo, C., Chen, S., Ma, J., Wang, J., Liang, X., Zheng, L., Liu, H., Effect of acid on the aggregation of poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) block copolymers. J. Phys. Chem. B 110 (2006), 23068–23074.
38. Zahoor, A., Sharma, S., Khuller, G., Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int. J. Antimicrob. Agents 26 (2005), 298–303.
39. Zhai, Y., Yang, X., Zhao, L., Wang, Z., Zhai, G., Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation. Int. J. Pharm. 471 (2014), 103–111.
40. Zhao, S., Li, N., Garamus, V.M., Handge, U.A., Liu, J., Zhang, R., Willumeit-Römer, R., Zou, A., Doxorubicin hydrochloride-oleic acid conjugate loaded nanostructured lipid carriers for tumor specific drug release. Colloids Surf. B Biointerfaces 145 (2016), 95–103.